These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Deletion insertion polymorphism of the angiotensin converting enzyme gene and progression of diabetic nephropathy. Björck S; Blohmé G; Sylvén C; Mulec H Nephrol Dial Transplant; 1997; 12 Suppl 2():67-70. PubMed ID: 9269704 [TBL] [Abstract][Full Text] [Related]
27. The novella about diabetic nephropathy. Ivanac-Janković R; Lovčić V; Magaš S; Šklebar D; Kes P Acta Clin Croat; 2015 Mar; 54(1):83-91. PubMed ID: 26058248 [TBL] [Abstract][Full Text] [Related]
28. Pancreas transplantation for the prevention of diabetic nephropathy. Stegall MD; Larson TS; Kudva YC; Grande JP; Nyberg SL; Prieto M; Velosa JA; Rizza RA Mayo Clin Proc; 2000 Jan; 75(1):49-56. PubMed ID: 10630757 [TBL] [Abstract][Full Text] [Related]
29. Effects of the angiotensin II type 1 receptor antagonist candesartan, compared with angiotensin-converting enzyme inhibitors, on the urinary excretion of albumin and type IV collagen in patients with diabetic nephropathy. Sato A; Tabata M; Hayashi K; Saruta T Clin Exp Nephrol; 2003 Sep; 7(3):215-20. PubMed ID: 14586718 [TBL] [Abstract][Full Text] [Related]
30. Prevention of loss of renal function over time in patients with diabetic nephropathy. Barnett A Am J Med; 2006 May; 119(5 Suppl 1):S40-7. PubMed ID: 16563947 [TBL] [Abstract][Full Text] [Related]
31. Diabetic nephropathy: common questions. Thorp ML Am Fam Physician; 2005 Jul; 72(1):96-9. PubMed ID: 16035688 [TBL] [Abstract][Full Text] [Related]
33. Renal protection in diabetic patients: benefits of a first-line combination of perindopril-indapamide (Preterax). Ruilope LM; Segura J J Hypertens Suppl; 2006 May; 24(3):S9-12. PubMed ID: 16723864 [TBL] [Abstract][Full Text] [Related]
34. Low-dose angiotensin converting enzyme inhibitors: effect on renal function in normo- and hypertensive type 1 diabetic patients. Ciavarella A; Mustacchio A; Silletti A; Franchi R; Levorato M; Campieri C; Borgnino LC; Capozzi G; Morotti L; Vannini P Eur J Med; 1992 Sep; 1(5):268-72. PubMed ID: 1341608 [TBL] [Abstract][Full Text] [Related]
35. Risk factors for development and progression of diabetic kidney disease and treatment patterns among diabetic siblings of patients with diabetic kidney disease. Bleyer AJ; Sedor JR; Freedman BI; O'Brien A; Russell GB; Graley J; Schelling JR Am J Kidney Dis; 2008 Jan; 51(1):29-37. PubMed ID: 18155530 [TBL] [Abstract][Full Text] [Related]
36. Hypertension and renal complications in type 2 diabetes. Nosadini R Semin Vasc Med; 2002 Feb; 2(1):109-19. PubMed ID: 16222601 [TBL] [Abstract][Full Text] [Related]
37. The emerging concept of chronic kidney disease without clinical proteinuria in diabetic patients. Halimi JM Diabetes Metab; 2012 Oct; 38(4):291-7. PubMed ID: 22622176 [TBL] [Abstract][Full Text] [Related]
38. [Diabetic nephropathy: diagnosis and therapy]. Hasslacher C Ther Umsch; 1996 Dec; 53(12):943-7. PubMed ID: 9036572 [TBL] [Abstract][Full Text] [Related]
39. Diabetic Nephropathy Remission and Regression Team Trial in Japan (DNETT-Japan): Rationale and study design. Shikata K; Haneda M; Koya D; Suzuki Y; Tomino Y; Yamada K; Maeda S; Kawakami N; Uzu T; Nishimura M; Sato C; Ogawa D; Makino H; Diabetes Res Clin Pract; 2010 Feb; 87(2):228-32. PubMed ID: 19889469 [TBL] [Abstract][Full Text] [Related]
40. Effects of multiple factorial intervention on ambulatory BP profile and renal function in hypertensive type 2 diabetic patients with overt nephropathy - a pilot study. Kanaoka T; Tamura K; Moriya T; Tanaka K; Konno Y; Kondoh S; Toyoda M; Umezono T; Fujikawa T; Ohsawa M; Dejima T; Maeda A; Wakui H; Haku S; Yanagi M; Mitsuhashi H; Ozawa M; Okano Y; Ogawa N; Yamakawa T; Mizushima S; Suzuki D; Umemura S Clin Exp Hypertens; 2011; 33(4):255-63. PubMed ID: 21699452 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]